-
Morningstar Analyst: Abbott Laboratories' Acquisition Of St. Jude Medical 'Makes A Lot Of Strategic Sense'
Thursday, April 28, 2016 - 2:06pm | 275Read More...Debbie Wang, an analyst at Morningstar explained during an interview on Bloomberg TV why Abbott Laboratories (NYSE: ABT) acquisition of St. Jude Medical, Inc. (NYSE: STJ) "makes a lot of strategic sense." Speaking to Bloomberg TV, Wang said that the deal is attractive due to healthcare reform. "The...


